Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A carbapenem (most often imipenem) was found in a prospective observational study to be the optimal choice for therapy of bacteremia due to ESBL-producing <I>Klebsiella pneumoniae</I>.

Treatment of Bacteremia Due to ESBL-Producing Klebsiella pneumoniae